TORONTO, Feb. 13, 2023 (GLOBE NEWSWIRE) -- Tilray Brands, Inc. ("Tilray" or the "Company") (Nasdaq: TLRY; TSX: TLRY), a leading global cannabis-lifestyle and consumer packaged goods company today announced the expansion of their best-selling Good Supply cannabis brand portfolio and the launch of their latest flower campaign. SweetWater Spirits are tasty libations, featuring premium vodka and real citrus fruit juices. Tilray is a global pioneer in the research, cultivation, production, and distribution of cannabis and cannabinoids, currently serving tens of thousands of patients and consumers in 16 countries spanning five continents. A pioneer in cannabis research, cultivation, and distribution, Tilray’s unprecedented production platform supports over 20 brands in over 20 countries, including comprehensive cannabis offerings, hemp-based foods, and alcoholic beverages. 48 hours. Brendan Kennedy, Tilray’s Chief Executive Officer, said, "Tilray is committed to quality and patient safety, and we look forward to significantly improving the quality of lives of Portuguese patients through our medical cannabis products. The Company is not able to reconcile these forward-looking non-GAAP financial measures to their most directly comparable forward-looking GAAP financial measures without unreasonable efforts because the Company is unable to predict with a reasonable degree of certainty the type and extent of certain items that would be expected to impact GAAP measures but would not impact the non-GAAP measures. Claim your brand to make shopping your products an easy and seamless experience on Leafly. One of Atlanta’s original craft breweries, founded 26 years ago, SweetWater Brewing is now the 9th largest craft brewers in the U.S. With two flagship breweries in Atlanta, Georgia and Fort Collins, Colorado, SweetWater’s award-winning craft beers and ready-to-drink cocktails are available coast to coast and in more states than ever before. Tilray : Investors [10] In July 2018, it became the first cannabis company to trade publicly on a major U.S. stock exchange,[13] opening on the NASDAQ exchange at a price of $17 per share, which increased in September 2018 to $214 per share, and then descended to $29 per share by August 2019. Tilray : Sweetwater Brewing Launches New Refreshing Line of Ready-to ... At Good Supply, however you roll, there’s a strain for you. For more information, visit: www.aphria.ca. Tilray A pioneer in cannabis research, cultivation, and distribution, Tilray Brands’ unprecedented production platform supports over 20 brands in over 20 countries, including comprehensive cannabis offerings, hemp-based foods, and craft beverages. ↳ Show More. We are committed to Certain material factors, estimates, goals, projections, or assumptions were used in drawing the conclusions contained in the forward-looking statements throughout this communication. tilray.com +493062933050. According to Infarmed and Portuguese Medicinal Cannabis regulations, Tilray medical cannabis products are approved for the treatment of Spasticity associated with Multiple Sclerosis or spinal cord injuries; nausea, vomiting (resulting from chemotherapy, radiation therapy, and combined HIV medication for hepatitis C); appetite stimulation in the palliative care of patients undergoing oncological treatment or with HIV/AIDS; Tourette syndrome, Epilepsy, and treatment of severe seizure disorders in children; therapeutic-resistant Glaucoma and chronic pain (associated with oncological or nervous system diseases such as neuropathic pain injury caused by nerve damage, phantom limb pain, trigeminal neuralgia, or after herpes zoster). Forward-looking statements can be identified by words such as “forecast,” “future,” “should,” “could,” “enable,” “potential,” “contemplate,” “believe,” “anticipate,” “estimate,” “plan,” “expect,” “intend,” “may,” “project,” “will,” “would” and the negative of these terms or similar expressions, although not all forward-looking statements contain these identifying words. Tilray Brands, Inc. (Nasdaq: TLRY; TSX: TLRY), is a leading global cannabis-lifestyle and consumer packaged goods company with operations in Canada, the United States, Europe, Australia, and Latin America that is changing people's lives for the better - one person at a time - by inspiring and empowering the worldwide community to live their very. [28], In July 2019, Tilray acquired U.K.-based Smith & Sinclair to develop CBD-infused edibles. [25] Manitoba Harvest's products are available in approximately 13,000 U.S. stores and 3,600 in Canada. [34] In partnership with the Grupo Español de Investigación en Neurooncología GEINO, in Spain, Tilray supplied medical cannabis products for the trial testing the efficacy and tolerability of medical cannabis as a possible treatment for glioblastoma. On a constant currency basis, net revenue increased by 29%. Pioneering the Future of Medical Cannabis Globally, Back With a strong belief that an evolving scientific understanding of the cannabis industry is necessary to completely understand the benefits and risks of cannabis-based medicine, Tilray has a created a clinical research program with research partners at leading hospitals and universities around the world. The certification also authorizes Tilray to manufacture bulk extracts on-site to sell as cannabis API (active pharmaceutical ingredients) and provides additional quality control lab capacity further to advance its ability for product innovation and research. time frame that matters. [9], Founded in 2014, Tilray was originally incorporated under the umbrella of Seattle-based Privateer Holdings and was one of Canada’s first licensed producers. Certain material factors, estimates, goals, projections or assumptions were used in drawing the conclusions contained in the forward-looking statements throughout this communication. On February 9, 2021, we announced a new agreement with Grow Pharma to import and distribute Tilray medical cannabis products in the United Kingdom. Adjusted EBITDA increased 17.8% to $48.0 million in fiscal year 2022 from $40.8 million in the prior fiscal year. Media Tilray Australia and New Zealand is dedicated to supporting healthcare professionals and patients in the region with access to our medicinal cannabis products. Tilray Brands, Inc. (TLRY) Gains But Lags Market: What You Should Know Tilray takes ", Sascha Mielcarek, Tilray's Managing Director in Europe, says, "We are very proud of Infarmed's market authorization, which confirms Tilray’s medical cannabis products live up to the highest national and international quality standards.” He continued, “ Patient demands are increasing in Portugal and throughout Europe, and our objectives are to provide them with the safest and best quality medical cannabis products. . Join our weekly newsletter in which we share the top stories form the world of CBD. Tilray, Inc. Reports 2020 Full Fiscal Year and Fourth Quarter Results The Globe and Mail dubbed this partnership as ‘big-pharma’s first foray into cannabis’. To present this information for historical periods, current period net sales for entities reporting in currencies other than the U.S. dollar are translated into U.S. dollars at the average monthly exchange rates in effect during the corresponding period of the prior fiscal year, rather than at the actual average monthly exchange rate in effect during the current period of the current fiscal year. The market authorization was issued by Infarmed, the Portuguese National Authority of Medicines and Health Products, whose rigorous process in providing such consent is internationally recognized. Patients can access Tilray products through major pharmaceutical distribution channels throughout Portugal and other European markets. Tilray has several global partnerships including Abinbev, the world’s largest brewer with whom they will conduct research into THC and CBD-infused beverages. Tilray is the first GMP-certified medical cannabis producer to supply cannabis extracts. Available for a limited time only in British Columbia, Manitoba and Saskatchewan as a 3x0.5g pre-roll offering. This move lagged the S&P 500's daily gain of 1.45%. Access resources for your pharmacy and promote your business as an Tilray Medicinal Cannabis dispenser. Certain statements in this press release constitute forward-looking information or forward-looking statements (together, “forward-looking statements”) under Canadian securities laws and within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, that are intended to be subject to the “safe harbor” created by those sections and other applicable laws. Rooted in classic strains that punch above their weight, Good Supply has been one of the top-selling brands in the concentrates and pre-roll category within Canada and is known for its innovative take on its products across its expansive portfolio. We aspire to lead, legitimize and define the future of our industry by building the world's most trusted cannabis and hemp company. They have products available in extract form and dried flower. Ranjit Dhatt A reconciliation of Adjusted EBITDA to net loss, the most directly comparable GAAP measure, has been provided in the financial statement tables included below in this press release. Products by . In order to ensure product consistency, cuttings are taken from a mother / stock plant, which then grow into new plants with identical properties. Pioneering the Future of Medical Cannabis - Tilray EU For further information about SweetWater Brewing Company, please visit www.sweetwaterbrew.com and follow @SweetWaterBrew across all social platforms. The forward-looking statements included in this communication are made as of the date of this communication and the Company does not undertake any obligation to publicly update such forward-looking statements to reflect new information, subsequent events or otherwise unless required by applicable securities laws. By providing us with your email address, you agree to Leafly's Terms of Service and Privacy Policy. [12], By October 2018, the company had raised $1.1 billion. Private Securities Litigation Reform Act of 1995 and "forward-looking information" within the meaning of Canadian securities laws, or collectively, forward-looking statements. Inspired by the outdoors, SweetWater is a passionate advocate for healthy waterways and conservation initiatives. | Source: These actions should also contribute to bottom-line performance improvement through production efficiencies and cost reductions. Tilray 10:10 Balance is an oil-based extract product made from high-THC and high-CBD strains cultivated by Tilray. Since the closing of the Tilray-Aphria transaction, the Company has delivered $85 million in cost synergies, exceeding its original target of delivering $80 million of cost savings by the end of fiscal year 2023. Watermelon Pre-rolls: A new pre-roll strain that’s full of flavour. This press release and the accompanying tables include non-GAAP financial measures, including adjusted gross margin, Adjusted EBITDA and free cash flow. The launch of the Aphria-branded medical strips is a compelling proof point in this regard, and, given the growing expansion of medical cannabis across the globe, we believe we are exceptionally well-positioned in this high-growth, high-margin market moving forward. [24] The acquisition allowed Tilray to use Manitoba Harvest's retail distribution network to enter the U.S. CBD market. scientific research that leads to an improved quality of life for patients in a Irwin D. Simon, Tilray Brands’ Chairman and Chief Executive Officer, stated, “Over the past year, we have accelerated the optimization of our operations and sharpened execution against our most profitable core business opportunities in medical, adult-use, wellness, and beverage-alcohol across Canada, Europe, and the U.S. At the same time, we accelerated our growth potential through tactical execution and strategic initiatives that enable accelerated revenue growth through improved cultivation, brand building, and distribution. 2103, Tilray Brands Media: Berrin Noorata, news@tilray.com, Tilray Brands Investors: Raphael Gross, (203) 682-8253, Raphael.Gross@icrinc.com. They were one of the first licensed medical cannabis companies in Canada, the first company to legally export medical cannabis to North America from Australia and New Zealand, and the first company to legally export medical cannabis to Europe from North America. Good Supply's latest product lineup includes: Orange Frosting Flower: Full of orange and floral aromas thanks to its rich and unique terpene profile, this new Sativa -leaning Hybrid delivers on uplifting enjoyment. Tilray PDF Tilray PURIFIED ORAL SOLUTION CBD100 Consolidated Statements of Financial Position, Condensed Consolidated Statements of Net Income (Loss) and Comprehensive Income (Loss), Adjusted Earnings before Interest, Taxes, and Amortization, Current portion of convertible notes receivable, Common stock ($0.0001 par value; 990,000,000 shares authorized; 532,674,887 and 446,440,641 shares issued and outstanding, respectively), Accumulated other comprehensive (deficit) income (loss), Change in fair value of contingent consideration, Revenue from Canadian medical cannabis products, Revenue from Canadian adult-use cannabis products, Revenue from international cannabis products, Gross profit (excluding inventory valuation adjustments and step-up), Cannabis gross margin (excluding inventory valuation adjustments and step-up), Beverage gross margin (excluding inventory valuation adjustments and step-up), Distribution gross margin (excluding inventory valuation adjustments and step-up), Wellness gross margin (excluding inventory valuation adjustments and step-up). Highlights of Strategic Growth Actions in Fiscal 2022. “We have crafted delicious and refreshing low-calorie cocktails using premium vodka, ensuring a sensory experience that surpasses expectations.”. Tilray®. Investors may join the live webcast available on the Investors section of the Company’s website at www.tilray.com. To ensure the most secure and best overall experience on our website, we recommend the latest versions of. Adjusted EBITDA of $11.5 million, marking the Company’s 13th consecutive quarter of positive Adjusted EBITDA. How it works; Library; Stories . A global leader in cannabis research, cultivation, processing and distribution. In 2019, Tilray purchased Manitoba Harvest, the world’s largest producer of hemp-based foods for $318 million. This process is called cloning. Forward-looking statements are not a guarantee of future performance and are based upon a number of estimates and assumptions of management in light of management's experience and perception of trends, current conditions, and expected developments, as well as other factors that management believes to be relevant and reasonable in the circumstances, including assumptions in respect of current and future European market conditions, the current and future regulatory environment and future approvals and permits. LEAMINGTON, ON and NANAIMO, BC, Feb. 23, 2021 /PRNewswire/ - Aphria Inc. (" Aphria ") (TSX: APHA andNASDAQ: APHA ), a leading global cannabis-lifestyle consumer packaged goods company inspiring and. is unmatched worldwide. NEW YORK & LEAMINGTON, Ontario-- ( BUSINESS WIRE )--Tilray, Inc. ("Tilray") (NASDAQ | TSX: TLRY), a leading global cannabis-lifestyle and consumer packaged goods company, today announced the. This press release contains "forward-looking statements" within the meaning of the U.S. [32] Led by The Hospital for Sick Children, in Toronto, Canada, Tilray provided a cannabidiol (CBD) oil product available in Canada to test the efficacy and tolerability of medical cannabis oil as a possible treatment for pediatric epilepsy (Dravet syndrome). Over time, the app will continue to learn which products and dosages deliver the best results for certain conditions. ranjit@pomppr.com, Investors Tilray is a global leader in medical cannabis research and production dedicated to providing safe, consistent and reliable therapy to patients. MyDosage isn’t just about you. This new agreement gives doctors and patients access to a sustainable supply of Tilray's full range of . Tilray Brands delivers on this mission by inspiring and empowering the worldwide community to live their very best life and providing access to products that meet the needs of their mind, body . 10:10 Balance Oil | Tilray - MyDosage This brand hasn’t claimed their profile yet. Net revenue increased 22% to $628.4 million during fiscal 2022 from $513.1 million in the prior fiscal year. Irwin D. Simon, Tilray’s Chairman and Chief Executive Officer, said, “Tilray’s medical brands, Aphria, Symbios, and Tilray, are relentlessly committed to investing in patient wellness through a portfolio of new innovative product offerings, GMP-certified cultivation, and the earned trust of the medical community. [26] The acquisition doubled the cultivation ability of the company in Canada. Tilray’s mission is to be the trusted partner for its patients and consumers by providing them with a cultivated experience and health and wellbeing through high-quality, differentiated brands and innovative products. Login, Please enter your company and pharmacy information here to proceed further, ABN is already in use or reset your password Reset. Available in Ontario only in 14g. Your support ID is: 17036164252096306786. Further, with the benefit of an additional $80 million of shared cost savings, synergies and financial benefits over the next two years associated with the HEXO transaction, management expects that Tilray Brands will be free cash flow positive in its business units in fiscal year 2023. Tilray Purified Oral Solution CBD100 2. All rights reserved. Data Provided by Refinitiv. [29] In August 2019, Tilray acquired Alberta cannabis retailer, Four20. A hand-rolled 2g ball with a shiny, dark brown exterior, and potent THC. Cannabinoid products | Putting patients first | Tilray | Health Europa On a constant currency basis, net revenue increased 14.5%. Tilray Expands Medical Cannabis Product Offering in Australia Tilray’s mission is to be the trusted partner for its patients and consumers by providing them with a cultivated experience and health and wellbeing through high-quality, differentiated brands and innovative products. For more information about Tilray medical cannabis products, visit: www.Tilray.caFor more information about Tilray, visit www.Tilray.com. Register as a Pharmacy. 647-890-2445 [37] In partnership with New York University, Tilray supplied CBD for a clinical trial studying its possible efficacy for treating disorders caused by breast cancer treatments. Progress on Expanding International Medical Business and Canadian Adult-Use Product Line. We are confident that as demand increases around the world and more (regulated or authorized) medical cannabis markets emerge, Tilray’s EU campus is ready to serve more partners and patients across the EU and other international medical markets.”. Forward-looking statements include statements regarding our intentions, beliefs, projections, outlook, analyses, or current expectations. Tilray Brands, Inc. (Nasdaq: TLRY and TSX: TLRY) is a leading global cannabis-lifestyle and consumer packaged goods company with operations in Canada, the United States, Europe, Australia, and Latin America that is changing people's lives for the better - one person at a time - by inspiring and empowering the worldwide community to live their ve. They should be read only in connection with the Company's Consolidated Statements of Operations and Cash Flows presented in accordance with GAAP. Wenn Sie Ihre Auswahl anpassen möchten, klicken Sie auf „Datenschutzeinstellungen verwalten“. December 02, 2021 07:30 ET For further information: Berrin Noorata Many factors could cause actual results, performance, or achievement to be materially different from any forward-looking statements, and other risks and uncertainties not presently known to the Company or that the Company deems immaterial could also cause actual results or events to differ materially from those expressed in the forward-looking statements contained herein. ATLANTA, May 30, 2023 (GLOBE NEWSWIRE) -- SweetWater Brewing Company ("SweetWater Brewing" or "SweetWater"), the ninth largest craft brewer in the U.S. and a subsidiary of Tilray Brands, Inc. (NASDAQ: TLRY and TSX: TLRY), today announces the launch of SweetWater Spirits, a new collection of bright and refreshing ready-to-drink mixed cocktails in a can featuring two spirits-based . Tilray Announces Launch of New Medical Cannabis Brand, Symbios The plant is then grown, flowered and finally harvested under continuously monitored, constant conditions. All of our products are developed with meticulous care to ensure the highest quality, consistency and purity for patients around the world. NANAIMO, British Columbia--(BUSINESS WIRE)--Tilray, Inc. (NASDAQ: TLRY), a global pioneer in cannabis research, cultivation, production, and distribution, today announced that it has received the necessary approvals and market authorization in accordance with the Portuguese legislation to offer Tilray medical cannabis products in Portugal from its GMP-certified EU facility in Cantanhede, Portugal. Made to bring strain identities to life, the Bud Squad campaign serves as a conversation starter among budtenders and consumers about signature and recognizable Good Supply core offerings. The complete GMP-certification allows Tilray to manufacture medical cannabis extracts in-house and export GMP-produced finished medical cannabis products, both dried flower, and oil, from Portugal . ATLANTA , May 30, 2023 (GLOBE NEWSWIRE) -- SweetWater Brewing Company (“SweetWater Brewing” or “SweetWater”), the ninth largest craft brewer in the U.S. and a subsidiary of Tilray Brands, Inc. (NASDAQ: TLRY and TSX: TLRY), today announces the launch of SweetWater Spirits , a new collection of, Refinances a meaningful portion of our debt due in June 2024 , extending maturity to 2027 and locking in lower fixed interest rate of 5.20%; Strengthens balance sheet with additional cash proceeds of $15 million or $37 million if over-allotment is exercised in full, to be used for strategic, Convertible notes offer lower interest expense and fewer covenant restrictions than our non-convertible debt options due to the conversion option value and are less dilutive than issuance of common stock A portion of the proceeds will be used to refinance existing debt LEAMINGTON, Ontario and NEW, Sweetwater Brewing Launches New Refreshing Line of Ready-to-Drink Mixed Cocktails in a Can, Tilray Brands, Inc. Tilray Meaning every time you give feedback, you’ll be helping someone else find their best dosage faster. Tilray also recently purchased UK-based company Smith & Sinclair to create CBD-infused edibles. Certain statements in this communication that are not historical facts constitute forward-looking information or forward-looking statements (together, “forward-looking statements”) under Canadian securities laws and within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, that are intended to be subject to the “safe harbor” created by those sections and other applicable laws. Management believes that the non-GAAP financial measures presented provide useful additional information to investors about current trends in the Company's operations and are useful for period-over-period comparisons of operations. [17] In December 2018, the company signed a deal with Novartis subsidiary Sandoz to sell, distribute and co-brand Tilray's non-smokeable/non-combustible medical cannabis products in legal markets worldwide. Forward-looking statements can be identified by words such as “forecast,” “future,” “should,” “could,” “enable,” “potential,” “contemplate,” “believe,” “anticipate,” “estimate,” “plan,” “expect,” “intend,” “may,” “project,” “will,” “would” and the negative of these terms or similar expressions, although not all forward-looking statements contain these identifying words. Patients looking to use medical cannabis have access to Tilray products by . Certain statements in this communication that are not historical facts constitute forward-looking information or forward-looking statements (together, “forward-looking statements”) under Canadian and U.S. securities laws and within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, that are intended to be subject to the “safe harbor” created by those sections and other applicable laws. Tilray makes cannabinoid medicinal products available to patients in a time frame that matters and urges others to do the same. Tilray : Tilray, Inc. Reports Profitable Second Quarter Fiscal Year ... [38], "Tilray Focuses on Brand Growth in Crowded Canada Pot Market", "Tilray Brands, Inc. Class 2 Common Stock (TLRY)", "Tilray Stands Out with its Global Supply Agreements", "Tilray exports medical cannabis to New Zealand for national dispersal", "Tilray sets up Latin American subsidiary", "Tilray to build $30 million EU cannabis production operation in Portugal - Financial Post", "Tilray Stock: As Germany Closes in on Legal Cannabis, Rest of Europe Might Follow", "Aphria, Tilray combine to create biggest cannabis company", "Tilray Commences Trading on the Toronto Stock Exchange Under Symbol "TLRY", "Seattle's Privateer launches $100M IPO for its Canadian marijuana company", "Tilray IPO: Five things to know about the first pot company to go public on Nasdaq", "Tilray shows the highs, lows of investing in pot", "How the Canadian cannabis company Tilray became worth more than American Airlines", "Shares of pot company Tilray surge in first day of trading on Nasdaq", "Canadian producer Tilray to export medical cannabis to U.S. for clinical trial - Globalnews.ca", "Tilray Signs Deal With Big Pharma Company Sandoz", "Tilray Launches High Park Company to Produce and Distribute Adult-Use Cannabis in Canada", "Tilray Medical Receives Approval to Extend Market Authorization in Italy", "Big Pharma's first foray into cannabis arrives with Sandoz-Tilray deal | Financial Post", "Brewer AB InBev partners with Tilray to tap cannabis drink market", "Tilray signs creative $250-million revenue-sharing deal with U.S. brand powerhouse ABG | Financial Post", "Tilray Eyes CBD Food And Drink Market With Manitoba Harvest Acquisition", "Manitoba Harvest enters 'wild, wild west' CBD market in U.S.", "Tilray to Acquire Natura Naturals Holdings Inc. for up to C$70 Million Subject to Performance Milestones", "Tilray to buy Natura for up to $70M, doubling Canadian cannabis growing capacity | CTV News", "High Park Gardens Licensed Cannabis Greenhouse In Leamington To Close | windsoriteDOTcaNews", "Tilray acquires boozy candy company Smith & Sinclair to develop CBD edibles", "Tilray signs deal to acquire Alberta cannabis retailer Four20", "Tilray Brands Reports Third Quarter Fiscal Year 2023 Financial Results and Announces Accretive Acquisition of 100% of HEXO Corp", "First Canadian paediatric study of mixed THC/CBD cannabis oil shows promise for children with drug-resistant epilepsy", "UBC & Tilray Launch Clinical Trial to Study Medical Cannabis & PTSD - Business Examiner", "Tilray signs first deal to supply pot to Europe out of new Portugal facility", "Tilray partners with Coimbra University to study medical cannabis", "Canadian pot company Tilray ships CBD to US for clinical trials on alcohol and PTSD", https://en.wikipedia.org/w/index.php?title=Tilray&oldid=1149215852, This page was last edited on 10 April 2023, at 21:07. TLRY - Tilray Brands, Inc. Tilray. Visit www.sweetwaterbrew.com to discover the perfect craftsmanship, flavor, and refreshment blend with SweetWater Spirits’ Vodka Soda Citrus and Vodka Soda Punch. Tilray Brands, Inc. (Nasdaq: TLRY; TSX: TLRY), is a leading global cannabis-lifestyle and consumer packaged goods company with operations in Canada, the United States, Europe, Australia, and Latin America that is changing people's lives for the better – one person at a time.
Zeugniserlass Niedersachsen 2020,
Nach Mazedonien Auswandern,
Articles T